FindMyKOL
Clinical trialNCT07052266RecruitingInterventional

Trial of Combined Obstetric Carrier Screening and Hereditary Cancer Screening

SponsorWeill Medical College of Cornell UniversityEnrollment550Hereditary Cancer Syndromes
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The investigators hypothesize that pregnancy and preconception care may be a feasible and effective time to offer inherited cancer risk screening. This study will assess interest in cancer genetic testing among patients receiving routine prenatal or preconception/fertility care. The goal is to evaluate the acceptability of BRCA1/2 testing when offered alongside standard prenatal genetic screening. The study will also explore whether universal screening in this population could support early cancer prevention and be cost-effective, especially among underserved populations.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Newyork-Presbyterian Weill Cornell Medicine

    Brooklyn, New York, United States

    Not, yet, recruiting
  • Reproductive Medicine

    Brooklyn, New York, United States

    Recruiting
  • Reproductive Medicine

    New York, New York, United States

    Recruiting
  • Weill Cornell Medicine

    New York, New York, United States

    Melissa Frey, MD, MS
    Recruiting
  • Newyork-Presbyterian Weill Cornell Medicine Queens

    Queens, New York, United States

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Sept 2025
Primary completion
30 Jun 2027
Completion
31 Dec 2028
Last update posted
26 Dec 2025
Registered enrollment
550
Registry id
NCT07052266

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.